Literature DB >> 9279210

Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.

J M Siegfried1, M A DeMichele, J D Hunt, A G Davis, K P Vohra, J M Pilewski.   

Abstract

Bombesin-like peptides (BLPs) are important regulators of lung development and may also act as autocrine growth factors in lung tumors. We have previously demonstrated expression of mRNA for the three BLP receptor subtypes (neuromedin B [NMB]) receptor, gastrin-releasing peptide [GRP] receptor, and bombesin receptor subtype 3 [BRS-3]) in human non-small cell lung carcinoma (NSCLC) cell lines and bronchial biopsies using the reverse transcription-polymerase chain reaction (RT-PCR; DeMichele, et al. Am. J. Respir. Cell Mol. Biol. 1994; 11:66-74). We have also previously found that growth responses to BLPs could be elicited in some, but not all, cultures of human bronchial epithelial (HBE) cells (Siegfried, et al. Anat. Rec. 1993; 236:241-247). In this report, we utilized RT-PCR to demonstrate mRNA expression of BLP receptor subtypes in cultured HBE cells and also assessed the response of these cultures to BLPs in proliferation assays. The pattern of mRNA expression was correlated with proliferative response, and the results were also analyzed in relation to smoking history and pulmonary function of the subjects studied. Our results suggest that expression of mRNA for the GRP receptor is associated with a long smoking history (> 25 pack-years [PY], p = 0.02). This association was related to past tobacco exposure, regardless of whether the subjects were still active smokers at the time of tissue procurement. Responsiveness to GRP and NMB in proliferation assays was also found only in those HBE cultures with expression of mRNA for at least one of the known receptors for BLPs, and there was a significant association between expression of mRNA for the GRP receptor and proliferative response to both GRP and NMB (p = 0.048). HBE cultures from subjects with a greater than 25 PY smoking history were also more likely to respond to BLPs in the proliferation assays than cells from subjects with less than a 25 PY history (10 of 16 versus 1 of 7, p = 0.06). Cultures of HBE cells from four of the five subjects with severe obstructive lung disease gave a positive response to GRP and NMB in proliferation assays, compared to five of fifteen without severe obstructive lung disease, but this difference was not significant (p = 0.13). These results suggest there is an increased likelihood of expression of the GRP receptor mRNA in the respiratory epithelium of some individuals with a history of prolonged tobacco exposure, and that expression of the GRP receptor mRNA is accompanied by responsiveness to the mitogenic effects of BLPs. These effects appear to persist after smoking cessation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279210     DOI: 10.1164/ajrccm.156.2.9608047

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Elevated gastrin-releasing peptide receptor mRNA expression in buccal mucosa: association with head and neck squamous cell carcinoma.

Authors:  Ann Marie Egloff; Xuwan Liu; Autumn L Gaither Davis; Brian K Trevelline; Marike Vuga; Jill M Siegfried; Jennifer R Grandis
Journal:  Head Neck       Date:  2012-03-20       Impact factor: 3.147

Review 2.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

3.  Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.

Authors:  Celia A Kanashiro; Andrew V Schally; Kate Groot; Patricia Armatis; Andrea L F Bernardino; Jozsef L Varga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

4.  Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.

Authors:  Florian Hohla; Andrew V Schally; Celia A Kanashiro; Stefan Buchholz; Benjamin Baker; Chandrika Kannadka; Angelika Moder; Elmar Aigner; Christian Datz; Gabor Halmos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

5.  Radiation-induced lung injury is mitigated by blockade of gastrin-releasing peptide.

Authors:  Shutang Zhou; Esther Nissao; Isabel L Jackson; Wei Leong; Lindsay Dancy; Frank Cuttitta; Zeljko Vujaskovic; Mary E Sunday
Journal:  Am J Pathol       Date:  2013-02-08       Impact factor: 4.307

Review 6.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

7.  Gastrin-releasing peptide receptor expression in non-cancerous bronchial epithelia is associated with lung cancer: a case-control study.

Authors:  Ann Marie Egloff; Autumn Gaither Davis; Yongli Shuai; Stephanie Land; Joseph M Pilewski; James D Luketich; Rodney Landreneau; York E Miller; Jennifer R Grandis; Jill M Siegfried
Journal:  Respir Res       Date:  2012-02-01

8.  Successful establishment of primary small airway cell cultures in human lung transplantation.

Authors:  Balarka Banerjee; Anthony Kicic; Michael Musk; Erika N Sutanto; Stephen M Stick; Daniel C Chambers
Journal:  Respir Res       Date:  2009-10-26

Review 9.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.